Rozenberg Julian M, Tesfu Daniel B, Musunuri Srilaxmi, Taylor Joan M, Mack Christopher P
From the Department of Pathology, University of North Carolina, Chapel Hill.
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2624-31. doi: 10.1161/ATVBAHA.114.304634. Epub 2014 Oct 16.
The goal of the present study was to identify novel mechanisms that regulate smooth muscle cell (SMC) differentiation marker gene expression.
We demonstrate that the CArG-containing regions of many SMC-specific promoters are imbedded within CpG islands. A previously identified GC repressor element in the SM myosin heavy chain (MHC) promoter was highly methylated in cultured aortic SMC but not in the aorta, and this difference was inversely correlated with SM MHC expression. Using an affinity chromatography/mass spectroscopy-based approach, we identified the multifunctional Notch transcription factor, recombination signal binding protein for immunoglobulin κ J region (RBPJ), as a methylated GC repressor-binding protein. RBPJ protein levels and binding to the endogenous SM MHC GC repressor were enhanced by platelet-derived growth factor-BB treatment. A methylation mimetic mutation to the GC repressor that facilitated RBPJ binding inhibited SM MHC promoter activity as did overexpression of RBPJ. Consistent with this, knockdown of RBPJ in phenotypically modulated human aortic SMC enhanced endogenous SMC marker gene expression, an effect likely mediated by increased recruitment of serum response factor and Pol II to the SMC-specific promoters. In contrast, the depletion of RBPJ in differentiated transforming growth factor-β-treated SMC inhibited SMC-specific gene activation, supporting the idea that the effects of RBPJ/Notch signaling are context dependent.
Our results indicate that methylation-dependent binding of RBPJ to a GC repressor element can negatively regulate SM MHC promoter activity and that RBPJ can inhibit SMC marker gene expression in phenotypically modulated SMC. These results will have important implications on the regulation of SMC phenotype and on Notch-dependent transcription.
本研究的目的是确定调节平滑肌细胞(SMC)分化标志物基因表达的新机制。
我们证明,许多SMC特异性启动子中含CArG的区域嵌入在CpG岛中。先前在平滑肌肌球蛋白重链(MHC)启动子中鉴定出的GC抑制元件在培养的主动脉SMC中高度甲基化,但在主动脉中未甲基化,这种差异与SM MHC表达呈负相关。使用基于亲和色谱/质谱的方法,我们鉴定出多功能Notch转录因子,免疫球蛋白κJ区重组信号结合蛋白(RBPJ),作为甲基化GC抑制结合蛋白。血小板衍生生长因子-BB处理可增强RBPJ蛋白水平及其与内源性SM MHC GC抑制因子的结合。促进RBPJ结合的GC抑制因子的甲基化模拟突变抑制了SM MHC启动子活性,RBPJ过表达也有同样的效果。与此一致,在表型调节的人主动脉SMC中敲低RBPJ可增强内源性SMC标志物基因表达,这种效应可能是由血清反应因子和Pol II向SMC特异性启动子的募集增加介导的。相反,在分化的转化生长因子-β处理的SMC中耗尽RBPJ会抑制SMC特异性基因激活,支持RBPJ/Notch信号传导的作用取决于背景的观点。
我们的结果表明,RBPJ与GC抑制元件的甲基化依赖性结合可负调节SM MHC启动子活性,并且RBPJ可抑制表型调节的SMC中的SMC标志物基因表达。这些结果将对SMC表型的调节和Notch依赖性转录具有重要意义。